Image source: © 2025 Krish Capital Pty.Ltd
Highlights
- Analysts set an average target price of USD50.14, reflecting cautious optimism on future gains.
- Institutional investors continue adjusting positions, with over 96% of shares held by large holders.
- Genpact posts quarterly EPS above estimates, though share price remains below its 200-day average.
Genpact Limited (NYSE:G), a global provider of business process outsourcing and IT services, has drawn a blend of ratings from Wall Street analysts in recent weeks, reflecting both confidence in its earnings track record and caution around valuation and market conditions.
Several analysts have updated their views on Genpact. Robert W. Baird trimmed its price target from USD56.00 to USD50.00, maintaining a “neutral” rating, signaling a measured approach despite steady operational results. Needham & Company LLC reaffirmed a “buy” rating with a USD50.00 price target, while Mizuho raised its target slightly from USD48.00 to USD51.00, also assigning a “neutral” outlook. Wall Street Zen took a more favorable stance, upgrading Genpact from “buy” to “strong-buy” in early June.
According to MarketBeat, Genpact currently carries a consensus rating of “Moderate Buy,” based on four “hold,” three “buy,” and one “strong buy” ratings. The average price target stands at USD50.14, modestly above the recent trading level of around USD45.92.
Investor activity indicates steady interest in the stock. Holdings Channel reported that Wealth Enhancement Advisory Services LLC boosted its stake in Genpact by acquiring an additional 1,651 shares last quarter, bringing its total to 9,650 shares valued at approximately USD486,000. Other firms, including Atlas Capital Advisors Inc., Stifel Financial Corp, and Fifth Third Bancorp, also increased their positions, suggesting continued institutional engagement. In total, roughly 96.03% of Genpact’s shares are held by institutional investors, indicating broad ownership among large market participants.
On the financial front, Genpact reported first-quarter earnings of USD0.84 per share, exceeding analysts’ consensus estimate of USD0.80. Revenue came in at USD1.21 billion, up 7.4% year-over-year, signaling consistent demand across its core segments. The company maintains a debt-to-equity ratio of 0.48 and a dividend yield of 1.48%, with an annual dividend payout of USD0.68 per share.
Despite outperforming estimates, Genpact’s stock has traded below its 200-day moving average of USD46.96, hovering around USD45.92 as of Friday. Shares remain within a one-year range of USD30.38 to USD56.76, reflecting the broader market’s mixed sentiment toward technology and outsourcing stocks.
Insider activity has also attracted attention. Director Nicholas C. Gangestad acquired 2,000 shares in May for approximately USD87,940, highlighting ongoing insider interest in the company’s prospects.






Please wait processing your request...